These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1696450)

  • 1. [Epidemiology of cancer of the prostate. Descriptive study].
    Bravo MP; de Palacio A; del Rey Calero J
    Arch Esp Urol; 1990 May; 43(4):349-52. PubMed ID: 1696450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors associated with cancer of the prostate].
    Pilar Bravo M; Castellanos E; del Rey Calero J
    Arch Esp Urol; 1990 Jun; 43(5):511-4. PubMed ID: 2389975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
    Kranjcević K; Marković BB
    Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height-related risk factors for prostate cancer.
    Norrish AE; McRae CU; Holdaway IM; Jackson RT
    Br J Cancer; 2000 Jan; 82(1):241-5. PubMed ID: 10638996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical history, sexual, and maturational factors and prostate cancer risk.
    Lightfoot N; Conlon M; Kreiger N; Sass-Kortsak A; Purdham J; Darlington G
    Ann Epidemiol; 2004 Oct; 14(9):655-62. PubMed ID: 15380796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
    Bright EA; Manuel C; Goddard JC; Khan MA
    Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?
    Izawa JI; Lega I; Downey D; Chin JL; Luke PP
    BJU Int; 2005 Aug; 96(3):320-3. PubMed ID: 16042722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
    Galić J; Simunović D
    Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-report of prostatitis and its risk factors in a random sample of middle-aged men.
    Rothman I; Stanford JL; Kuniyuki A; Berger RE
    Urology; 2004 Nov; 64(5):876-9; discussion 879-80. PubMed ID: 15533468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in Maiduguri.
    Yawe KT; Tahir MB; Nggada HA
    West Afr J Med; 2006; 25(4):298-300. PubMed ID: 17402521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.
    Berger AP; Deibl M; Steiner H; Bektic J; Pelzer A; Spranger R; Klocker H; Bartsch G; Horninger W
    Prostate; 2005 Aug; 64(3):240-5. PubMed ID: 15712213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.